Literature DB >> 17556183

The Japanese experience with metabolic imaging in the clinical setting.

Nagara Tamaki1, Koichi Morita, Yuko Kawai.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17556183     DOI： 10.1016/j.nuclcard.2007.02.012

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  55 in total

1.  Insulin resistance and impaired myocardial fatty acid metabolism in dialysis patients with normal coronary arteries.

Authors:  M Nishimura; M Murase; T Hashimoto; H Kobayashi; S Yamazaki; R Imai; K Okino; H Fujita; N Inoue; H Takahashi; T Ono
Journal:  Kidney Int       Date:  2006-02       Impact factor: 10.612

2.  Significance of reduced uptake of iodinated fatty acid analogue for the evaluation of patients with acute chest pain.

Authors:  Y Kawai; E Tsukamoto; Y Nozaki; K Morita; M Sakurai; N Tamaki
Journal:  J Am Coll Cardiol       Date:  2001-12       Impact factor: 24.094

3.  Quantification of area at risk in acute myocardial infarction by tomographic imaging.

Authors:  Y Furutani; T Shiigi; Y Nakamura; H Nakamura; M Harada; T Yamamoto; T Wakeyama; M Nakatsuka; H Ogawa; M Matsuzaki
Journal:  J Nucl Med       Date:  1997-12       Impact factor: 10.057

4.  Recovery of impaired left ventricular function in patients with acute myocardial infarction is predicted by the discordance in defect size on 123I-BMIPP and 201Tl SPET images.

Authors:  T Ito; J Tanouchi; J Kato; T Morioka; M Nishino; K Iwai; H Tanahashi; Y Yamada; M Hori; T Kamada
Journal:  Eur J Nucl Med       Date:  1996-08

5.  Combined study with I-123 fatty acid and thallium-201 to assess ischemic myocardium: comparison with thallium redistribution and glucose metabolism.

Authors:  M Kawamoto; N Tamaki; Y Yonekura; E Tadamura; Y Fujibayashi; Y Magata; R Nohara; S Sasayama; K Ikekubo; H Kato
Journal:  Ann Nucl Med       Date:  1994-02       Impact factor: 2.668

6.  Myocardial emission computed tomography with iodine-123-labeled beta-methyl-branched fatty acid in patients with hypertrophic cardiomyopathy.

Authors:  C Kurata; K Tawarahara; T Taguchi; S Aoshima; A Kobayashi; N Yamazaki; H Kawai; M Kaneko
Journal:  J Nucl Med       Date:  1992-01       Impact factor: 10.057

7.  Impairment of regional fatty acid uptake in relation to wall motion and thallium-201 uptake in ischaemic but viable myocardium: assessment with iodine-123-labelled beta-methyl-branched fatty acid.

Authors:  J Taki; K Nakajima; I Matsunari; H Bunko; S Takada; N Tonami
Journal:  Eur J Nucl Med       Date:  1995-12

8.  The relationship between clinical stage, prognosis and myocardial damage in patients with Duchenne-type muscular dystrophy: five-year follow-up study.

Authors:  Hitoshi Naruse; Junko Miyagi; Tohru Arii; Mitsumasa Ohyanagi; Tadaaki Iwasaki; Kenji Jinnai
Journal:  Ann Nucl Med       Date:  2004-05       Impact factor: 2.668

9.  Sustained regional abnormalities in cardiac metabolism after transient ischemia in the chronic dog model.

Authors:  M Schwaiger; H R Schelbert; D Ellison; H Hansen; L Yeatman; J Vinten-Johansen; C Selin; J Barrio; M E Phelps
Journal:  J Am Coll Cardiol       Date:  1985-08       Impact factor: 24.094

10.  Prognostic value of iodine-123 labelled BMIPP fatty acid analogue imaging in patients with myocardial infarction.

Authors:  N Tamaki; E Tadamura; T Kudoh; N Hattori; Y Yonekura; R Nohara; S Sasayama; K Ikekubo; H Kato; J Konishi
Journal:  Eur J Nucl Med       Date:  1996-03
View more
  4 in total

Review 1.  Myocardial perfusion scintigraphy: past, present and future.

Authors:  A Notghi; C S Low
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

2.  Proceedings of the ASNC cardiac PET summit meeting, May 12, 2014, Baltimore MD : 5. Advances in radiopharmaceutical availability and development of cardiac PET tracers.

Authors:  Manuel Cerqueira; James Case; Jamshid Maddahi
Journal:  J Nucl Cardiol       Date:  2015-07-01       Impact factor: 5.952

Review 3.  Novel iodinated tracers, MIBG and BMIPP, for nuclear cardiology.

Authors:  Nagara Tamaki; Keiichiro Yoshinaga
Journal:  J Nucl Cardiol       Date:  2011-02       Impact factor: 5.952

Review 4.  Ischaemic memory imaging using metabolic radiopharmaceuticals: overview of clinical settings and ongoing investigations.

Authors:  Keiichiro Yoshinaga; Masanao Naya; Tohru Shiga; Eriko Suzuki; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-11-12       Impact factor: 9.236
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.